BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31804632)

  • 41. Altered neural activity of magnitude estimation processing in adults with the fragile X premutation.
    Kim SY; Hashimoto R; Tassone F; Simon TJ; Rivera SM
    J Psychiatr Res; 2013 Dec; 47(12):1909-16. PubMed ID: 24045061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The FMR1 gene and fragile X-associated tremor/ataxia syndrome.
    Brouwer JR; Willemsen R; Oostra BA
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):782-98. PubMed ID: 19105204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations.
    Tabolacci E; Moscato U; Zalfa F; Bagni C; Chiurazzi P; Neri G
    Eur J Hum Genet; 2008 Dec; 16(12):1487-98. PubMed ID: 18628788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maternal FMR1 premutation allele expansion and contraction in fraternal twins.
    Alfaro MP; Cohen M; Vnencak-Jones CL
    Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
    Landowska A; Rzońca S; Bal J; Gos M
    Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile.
    Santa María L; Pugin A; Alliende MA; Aliaga S; Curotto B; Aravena T; Tang HT; Mendoza-Morales G; Hagerman R; Tassone F
    Clin Genet; 2014 Oct; 86(4):378-82. PubMed ID: 24028275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral protein synthesis in a knockin mouse model of the fragile X premutation.
    Qin M; Huang T; Liu Z; Kader M; Burlin T; Xia Z; Zeidler Z; Hukema RK; Smith CB
    ASN Neuro; 2014; 6(5):. PubMed ID: 25290064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
    Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Size and methylation mosaicism in males with Fragile X syndrome.
    Jiraanont P; Kumar M; Tang HT; Espinal G; Hagerman PJ; Hagerman RJ; Chutabhakdikul N; Tassone F
    Expert Rev Mol Diagn; 2017 Nov; 17(11):1023-1032. PubMed ID: 28929824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skewed X inactivation of the normal allele in fully mutated female carriers determines the levels of FMRP in blood and the fragile X phenotype.
    Martínez R; Bonilla-Henao V; Jiménez A; Lucas M; Vega C; Ramos I; Sobrino F; Pintado E
    Mol Diagn; 2005; 9(3):157-62. PubMed ID: 16271017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.
    Fatima T; Zaidi SA; Sarfraz N; Perween S; Khurshid F; Imtiaz F
    Am J Med Genet A; 2014 May; 164A(5):1151-61. PubMed ID: 24478267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mosaicism in Fragile X syndrome: A family case series.
    Saldarriaga W; González-Teshima LY; Forero-Forero JV; Tang HT; Tassone F
    J Intellect Disabil; 2022 Sep; 26(3):800-807. PubMed ID: 33998336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining the 3'Epigenetic Boundary of the
    Godler DE; Inaba Y; Bui MQ; Francis D; Skinner C; Schwartz CE; Amor DJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fragile X syndrome in females - a familial case report and review of the literature.
    Stembalska A; Łaczmańska I; Gil J; Pesz KA
    Dev Period Med; 2016; 20(2):99-104. PubMed ID: 27442693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in assays for the fragile X-related disorders.
    Hayward BE; Kumari D; Usdin K
    Hum Genet; 2017 Oct; 136(10):1313-1327. PubMed ID: 28866801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.